International psychometric validation of the Living with Chronic Illness Scale in Spanish-speaking patients with chronic obstructive pulmonary disease
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ..
OBJECTIVES: To validate the Living with Chronic Illness (LW-CI) Scale in patients with chronic obstructive pulmonary disease (COPD).
DESIGN: Observational, cross-sectional validation study with retest. Acceptability, reliability, precision and construct validity were tested.
SETTING: The study took place in primary and secondary specialised units of public and private hospitals of Spain and Colombia.
PARTICIPANTS: The study included 612 patients with COPD assessed from May 2018 to May 2019. A consecutive cases sampling was done. Inclusion criteria included: (A) patients with a diagnosis of COPD; (B) native Spanish speaking; (C) able to read and understand questionnaires; and (D) able to provide informed consent. Exclusion criteria included: (A) cognitive deterioration and (B) pharmacological effect or disorder that could disrupt the assessment.
RESULTS: The LW-CI-COPD presented satisfactory data quality, with no missing data or floor/ceiling effects, showing high internal consistency for all the domains (Cronbach's alpha for the total score 0.92). Test-retest reliability was satisfactory (intraclass correlation coefficient=0.92). The LW-CI-COPD correlated 0.52-0.64 with quality of life and social support measures. The scale demonstrated satisfactory known-groups validity, yielding significantly different scores in patients grouped according to COPD severity levels.
CONCLUSIONS: This has been the first validation study of the LW-CI-COPD. It is a feasible, reliable, valid and precise self-reported scale to measure living with COPD in the Spanish-speaking population. Therefore, it could be recommended for research and clinical practice to measure this concept and evaluate the impact of centred-care interdisciplinary interventions based on the patients' perspective, focused on providing holistic and comprehensive care to patients with COPD.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
---|---|
Enthalten in: |
BMJ open - 11(2021), 3 vom: 12. März, Seite e039973 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Corchon, Silvia [VerfasserIn] |
---|
Links: |
---|
Themen: |
Adult pathology |
---|
Anmerkungen: |
Date Completed 19.05.2021 Date Revised 11.11.2023 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.1136/bmjopen-2020-039973 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM322693675 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM322693675 | ||
003 | DE-627 | ||
005 | 20231226202725.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1136/bmjopen-2020-039973 |2 doi | |
028 | 5 | 2 | |a pubmed24n1075.xml |
035 | |a (DE-627)NLM322693675 | ||
035 | |a (NLM)33712522 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Corchon, Silvia |e verfasserin |4 aut | |
245 | 1 | 0 | |a International psychometric validation of the Living with Chronic Illness Scale in Spanish-speaking patients with chronic obstructive pulmonary disease |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 19.05.2021 | ||
500 | |a Date Revised 11.11.2023 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. | ||
520 | |a OBJECTIVES: To validate the Living with Chronic Illness (LW-CI) Scale in patients with chronic obstructive pulmonary disease (COPD) | ||
520 | |a DESIGN: Observational, cross-sectional validation study with retest. Acceptability, reliability, precision and construct validity were tested | ||
520 | |a SETTING: The study took place in primary and secondary specialised units of public and private hospitals of Spain and Colombia | ||
520 | |a PARTICIPANTS: The study included 612 patients with COPD assessed from May 2018 to May 2019. A consecutive cases sampling was done. Inclusion criteria included: (A) patients with a diagnosis of COPD; (B) native Spanish speaking; (C) able to read and understand questionnaires; and (D) able to provide informed consent. Exclusion criteria included: (A) cognitive deterioration and (B) pharmacological effect or disorder that could disrupt the assessment | ||
520 | |a RESULTS: The LW-CI-COPD presented satisfactory data quality, with no missing data or floor/ceiling effects, showing high internal consistency for all the domains (Cronbach's alpha for the total score 0.92). Test-retest reliability was satisfactory (intraclass correlation coefficient=0.92). The LW-CI-COPD correlated 0.52-0.64 with quality of life and social support measures. The scale demonstrated satisfactory known-groups validity, yielding significantly different scores in patients grouped according to COPD severity levels | ||
520 | |a CONCLUSIONS: This has been the first validation study of the LW-CI-COPD. It is a feasible, reliable, valid and precise self-reported scale to measure living with COPD in the Spanish-speaking population. Therefore, it could be recommended for research and clinical practice to measure this concept and evaluate the impact of centred-care interdisciplinary interventions based on the patients' perspective, focused on providing holistic and comprehensive care to patients with COPD | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Observational Study | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a adult pathology | |
650 | 4 | |a chronic airways disease | |
650 | 4 | |a quality in health care | |
700 | 1 | |a Rodriguez-Blazquez, Carmen |e verfasserin |4 aut | |
700 | 1 | |a Carvajal-Carrascal, Gloria |e verfasserin |4 aut | |
700 | 1 | |a Fuentes-Ramirez, Alejandra |e verfasserin |4 aut | |
700 | 1 | |a Ruiz de Ocenda, Manuel Ignacio |e verfasserin |4 aut | |
700 | 1 | |a Caparros, Neus |e verfasserin |4 aut | |
700 | 1 | |a Timonet-Andreu, Eva |e verfasserin |4 aut | |
700 | 1 | |a Navarta-Sanchez, Maria Victoria |e verfasserin |4 aut | |
700 | 1 | |a Ambrosio, Leire |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t BMJ open |d 2012 |g 11(2021), 3 vom: 12. März, Seite e039973 |w (DE-627)NLM215724372 |x 2044-6055 |7 nnns |
773 | 1 | 8 | |g volume:11 |g year:2021 |g number:3 |g day:12 |g month:03 |g pages:e039973 |
856 | 4 | 0 | |u http://dx.doi.org/10.1136/bmjopen-2020-039973 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 11 |j 2021 |e 3 |b 12 |c 03 |h e039973 |